It has been shown that after metastatic dissemination, keratinocyte-derived endothelin 3 (EDN3) the microenvironment provides signals to promote phenotype switching between invasive and proliferative states and provide proof that targeting tumor cell plasticity is a valuable therapeutic option. This evidence concerns the gene EDN3 and neoplasm.